Literature DB >> 9603216

(-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide.

W Maruyama1, T Takahashi, M Naoi.   

Abstract

In Parkinson's disease the cell death of dopamine neurons has been proposed to be mediated by an apoptotic death process, in which nitric oxide may be involved. This article reports the induction of apoptosis by nitric oxide and peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells and the antiapoptotic activity of (-)-deprenyl. After the cells were treated with a nitric oxide donor, NOR-4, or a peroxynitrite donor, SIN-1, DNA damage was quantitatively studied using a single-cell gel electrophoresis (comet) assay. NOR-4 and SIN-1 induced DNA damage dose-dependently. Cycloheximide and alkaline treatment of the cells prevented the DNA damage, indicating that the damage is apoptotic and that it depends on the intracellular signal transduction. Superoxide dismutase and the antioxidants reduced glutathione and alpha-tocopherol protected the cells from the DNA damage. (-)-Deprenyl protected the cells from the DNA damage induced by nitric oxide or peroxynitrite almost completely. The protection by (-)-deprenyl was significant even after it was washed from the cells, indicating that (-)-deprenyl may activate the intracellular system against apoptosis. These results suggest that (-)-deprenyl or related compounds may be neuroprotective to dopamine neurons through its antiapoptotic activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603216     DOI: 10.1046/j.1471-4159.1998.70062510.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.

Authors:  Keiko Inaba-Hasegawa; Yukihiro Akao; Wakako Maruyama; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2011-11-08       Impact factor: 3.575

Review 2.  Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai; Hong Yi; Yukihiro Akao; Masashi Tanaka
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  Neuroprotection by pharmacologic blockade of the GAPDH death cascade.

Authors:  Makoto R Hara; Bobby Thomas; Matthew B Cascio; Byoung-Il Bae; Lynda D Hester; Valina L Dawson; Ted M Dawson; Akira Sawa; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

Review 4.  Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2020-01-28       Impact factor: 3.575

5.  Effect of R-(-)-deprenyl and harmaline on dopamine- and peroxynitrite-induced membrane permeability transition in brain mitochondria.

Authors:  Chung Soo Lee; Chung Seok Lee; Hyun Hee Ko; Jin Ho Song; Eun Sook Han
Journal:  Neurochem Res       Date:  2002-03       Impact factor: 3.996

6.  Antiperoxidative and antiinflammatory effect of Sida cordifolia Linn. on quinolinic acid induced neurotoxicity.

Authors:  S S Swathy; Seema Panicker; R S Nithya; M M Anuja; S Rejitha; M Indira
Journal:  Neurochem Res       Date:  2010-05-25       Impact factor: 3.996

7.  Peroxynitrite induces neuronal cell death in aging and age-associated disorders: A review.

Authors:  W Maruyama; Y Kato; T Yamamoto; K Oh-Hashi; Y Hashizume; M Naoi
Journal:  J Am Aging Assoc       Date:  2001-01

8.  l-Deprenyl prevents lipid peroxidation and memory deficits produced by cerebral ischemia in rats.

Authors:  F D Maia; B S S Pitombeira; D T Aráujo; G M A Cunha; G S B Viana
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

9.  Anti-apoptotic function of propargylamine inhibitors of type-B monoamine oxidase.

Authors:  M Naoi; W Maruyama; M B H Youdim; P Yu; A A Boulton
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

10.  Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson's disease.

Authors:  Kay Cheong Teo; Shu-Leong Ho
Journal:  Transl Neurodegener       Date:  2013-09-08       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.